CA3016735A1 - Compositions, devices, and methods of functional dyspepsia sensitivity testing - Google Patents
Compositions, devices, and methods of functional dyspepsia sensitivity testing Download PDFInfo
- Publication number
- CA3016735A1 CA3016735A1 CA3016735A CA3016735A CA3016735A1 CA 3016735 A1 CA3016735 A1 CA 3016735A1 CA 3016735 A CA3016735 A CA 3016735A CA 3016735 A CA3016735 A CA 3016735A CA 3016735 A1 CA3016735 A1 CA 3016735A1
- Authority
- CA
- Canada
- Prior art keywords
- value
- determined
- average discriminatory
- food preparations
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 88
- 230000035945 sensitivity Effects 0.000 title claims abstract description 32
- 201000006549 dyspepsia Diseases 0.000 title claims description 175
- 238000012360 testing method Methods 0.000 title claims description 112
- 239000000203 mixture Substances 0.000 title abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 368
- 238000002360 preparation method Methods 0.000 claims abstract description 163
- 238000010998 test method Methods 0.000 claims abstract description 5
- 210000001124 body fluid Anatomy 0.000 claims description 21
- 238000002965 ELISA Methods 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 16
- 206010061958 Food Intolerance Diseases 0.000 claims description 13
- 239000006286 aqueous extract Substances 0.000 claims description 9
- 238000003556 assay Methods 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 208000019695 Migraine disease Diseases 0.000 claims description 5
- 230000000274 adsorptive effect Effects 0.000 claims description 5
- 239000011324 bead Substances 0.000 claims description 5
- 238000003745 diagnosis Methods 0.000 claims description 5
- 230000002550 fecal effect Effects 0.000 claims description 5
- 210000003296 saliva Anatomy 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 239000000969 carrier Substances 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims 4
- 206010027603 Migraine headaches Diseases 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 238000003149 assay kit Methods 0.000 abstract description 2
- 238000009826 distribution Methods 0.000 description 25
- 239000000284 extract Substances 0.000 description 22
- 230000004044 response Effects 0.000 description 18
- 241000238557 Decapoda Species 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 235000015277 pork Nutrition 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000013011 aqueous formulation Substances 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 240000005979 Hordeum vulgare Species 0.000 description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000013211 curve analysis Methods 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000013517 stratification Methods 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 206010027599 migraine Diseases 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
- 230000003979 response to food Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241001149922 Metacarcinus magister Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 235000020805 dietary restrictions Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 238000000528 statistical test Methods 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000981138 Allium flavum Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000530454 Litopenaeus schmitti Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 238000012952 Resampling Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 235000020785 dietary preference Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000006028 immune-suppresssive effect Effects 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000001558 permutation test Methods 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Optics & Photonics (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Glass Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662305680P | 2016-03-09 | 2016-03-09 | |
| US62/305,680 | 2016-03-09 | ||
| PCT/US2017/021643 WO2017156313A1 (en) | 2016-03-09 | 2017-03-09 | Compositions, devices, and methods of functional dyspepsia sensitivity testing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3016735A1 true CA3016735A1 (en) | 2017-09-14 |
Family
ID=59789894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3016735A Pending CA3016735A1 (en) | 2016-03-09 | 2017-03-09 | Compositions, devices, and methods of functional dyspepsia sensitivity testing |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190120835A1 (enExample) |
| EP (1) | EP3427056A4 (enExample) |
| JP (2) | JP2019509485A (enExample) |
| CN (1) | CN109154607A (enExample) |
| AU (1) | AU2017230706A1 (enExample) |
| CA (1) | CA3016735A1 (enExample) |
| MX (1) | MX2018010856A (enExample) |
| WO (1) | WO2017156313A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102375614B1 (ko) | 2014-11-14 | 2022-03-16 | 바이오메리카인코포레이티드 | Ibs 민감도 테스트 구성, 장치 및 방법 |
| WO2017156313A1 (en) * | 2016-03-09 | 2017-09-14 | Biomerica, Inc. | Compositions, devices, and methods of functional dyspepsia sensitivity testing |
| EP3497447B1 (en) | 2016-07-08 | 2024-09-04 | Biomerica, Inc. | Compositions, devices, and methods of depression sensitivity testing |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0310522D0 (en) * | 2003-05-08 | 2003-06-11 | Yorktest Lab Ltd | Assay panel |
| US20050255533A1 (en) * | 2004-02-10 | 2005-11-17 | Brendan Bioscience, Llc | Comprehensive food allergy test |
| US7601509B2 (en) * | 2004-07-15 | 2009-10-13 | Power Laura W | Biotype diets system: predicting food allergies by blood type |
| AR057828A1 (es) * | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
| WO2007099346A1 (en) * | 2006-03-03 | 2007-09-07 | Cambridge Antibody Technology Limited | Binding members for ghrelin |
| WO2009035529A1 (en) * | 2007-09-10 | 2009-03-19 | Immunohealth International, Llc | Method of analysis, detection and correction of food intolerance in humans |
| KR20110131262A (ko) * | 2009-03-05 | 2011-12-06 | 아지노모토 가부시키가이샤 | 크론병 진단 시약 |
| EP2533052A1 (en) * | 2011-06-07 | 2012-12-12 | B.R.A.H.M.S GmbH | Diagnostic use of proSomatostatin |
| US20150010914A1 (en) * | 2012-01-20 | 2015-01-08 | Adelaide Research & Innovation Pty Ltd. | Biomarkers for gastric cancer and uses thereof |
| EP2657707A1 (en) * | 2012-04-26 | 2013-10-30 | B.R.A.H.M.S GmbH | Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope |
| KR102332418B1 (ko) * | 2015-01-30 | 2021-11-26 | 사이렉스 래보라토리즈 엘엘씨 | 다수의 식품 항원들 및 c1q-식품 단백질 면역 복합체에 대한 igg 항체 및 iga 항체의 동시 특징분석 |
| WO2017156313A1 (en) * | 2016-03-09 | 2017-09-14 | Biomerica, Inc. | Compositions, devices, and methods of functional dyspepsia sensitivity testing |
-
2017
- 2017-03-09 WO PCT/US2017/021643 patent/WO2017156313A1/en not_active Ceased
- 2017-03-09 AU AU2017230706A patent/AU2017230706A1/en not_active Abandoned
- 2017-03-09 JP JP2018547376A patent/JP2019509485A/ja active Pending
- 2017-03-09 CA CA3016735A patent/CA3016735A1/en active Pending
- 2017-03-09 EP EP17764130.5A patent/EP3427056A4/en active Pending
- 2017-03-09 MX MX2018010856A patent/MX2018010856A/es unknown
- 2017-03-09 CN CN201780025319.1A patent/CN109154607A/zh active Pending
-
2018
- 2018-09-07 US US16/124,473 patent/US20190120835A1/en not_active Abandoned
-
2021
- 2021-12-10 JP JP2021201232A patent/JP2022031342A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20190120835A1 (en) | 2019-04-25 |
| WO2017156313A1 (en) | 2017-09-14 |
| EP3427056A4 (en) | 2019-11-06 |
| JP2022031342A (ja) | 2022-02-18 |
| MX2018010856A (es) | 2019-07-10 |
| EP3427056A1 (en) | 2019-01-16 |
| AU2017230706A1 (en) | 2018-09-27 |
| CN109154607A (zh) | 2019-01-04 |
| JP2019509485A (ja) | 2019-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2967817A1 (en) | Compositions, devices, and methods of ibs sensitivity testing | |
| JP7176791B2 (ja) | うつ病感受性試験の組成物、デバイスおよび方法 | |
| JP2024060100A (ja) | 潰瘍性大腸炎患者における食物感受性の検査キットパネルの作成方法 | |
| JP2022022426A (ja) | 線維筋痛症感受性試験の組成物、デバイスおよび方法 | |
| JP2022125268A (ja) | 胃食道逆流性疾患感受性試験の組成物、デバイスおよび方法 | |
| JP2022031342A (ja) | 機能性消化不良感受性試験の組成物、デバイスおよび方法 | |
| EP3394623B1 (en) | Compositions, devices, and methods of psoriasis food sensitivity testing | |
| EP4116713A2 (en) | Compositions, devices, and methods of osteoarthritis sensitivity testing | |
| JP7689378B2 (ja) | 注意欠陥障害／注意欠陥多動性障害（ａｄｄ／ａｄｈｄ）過敏性試験の組成物、デバイスおよび方法 | |
| US20190170768A1 (en) | Compositions, devices, and methods of crohn's disease sensitivity testing | |
| EP3394617B1 (en) | Compositions, devices, and methods of migraine headache food sensitivity testing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220308 |
|
| EEER | Examination request |
Effective date: 20220308 |
|
| EEER | Examination request |
Effective date: 20220308 |
|
| EEER | Examination request |
Effective date: 20220308 |